🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 hora
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/06/1993 | 17,53 | 17,59 | 17,35 | 17,47 | +0,00% | 1,36% | 3.219.875 |
| 04/06/1993 | 17,47 | 17,59 | 17,29 | 17,47 | -0,68% | 1,71% | 3.295.541 |
| 03/06/1993 | 17,59 | 17,83 | 17,53 | 17,59 | -1,01% | 1,69% | 3.486.067 |
| 02/06/1993 | 17,95 | 18,07 | 17,59 | 17,77 | -2,30% | 2,66% | 3.516.250 |
| 01/06/1993 | 18,31 | 18,31 | 18,13 | 18,19 | -0,33% | 0,98% | 3.605.958 |
| 28/05/1993 | 18,07 | 18,49 | 17,83 | 18,25 | +1,32% | 3,63% | 3.577.872 |
| 27/05/1993 | 18,67 | 18,79 | 17,95 | 18,01 | -3,21% | 4,47% | 4.156.997 |
| 26/05/1993 | 18,31 | 18,67 | 18,01 | 18,61 | +2,30% | 3,58% | 4.106.483 |
| 25/05/1993 | 18,19 | 18,31 | 18,07 | 18,19 | -0,65% | 1,31% | 2.447.499 |
| 24/05/1993 | 18,19 | 18,37 | 18,07 | 18,31 | +0,66% | 1,64% | 2.854.123 |
| 21/05/1993 | 18,43 | 18,67 | 18,19 | 18,19 | -2,56% | 2,59% | 5.515.414 |
| 20/05/1993 | 18,55 | 18,73 | 18,43 | 18,67 | +0,64% | 1,61% | 5.173.557 |
| 19/05/1993 | 18,43 | 18,61 | 18,19 | 18,55 | +1,30% | 2,27% | 6.404.118 |
| 18/05/1993 | 18,55 | 18,55 | 17,83 | 18,31 | -0,65% | 3,86% | 5.680.370 |
| 17/05/1993 | 18,25 | 18,55 | 17,89 | 18,43 | +3,34% | 3,59% | 6.487.539 |
| 14/05/1993 | 17,35 | 17,83 | 17,29 | 17,83 | +3,10% | 3,09% | 3.328.448 |
| 13/05/1993 | 17,24 | 17,47 | 17,06 | 17,29 | -1,36% | 2,42% | 3.960.392 |
| 12/05/1993 | 18,01 | 18,01 | 17,47 | 17,53 | -2,33% | 2,98% | 4.023.482 |
| 11/05/1993 | 18,07 | 18,13 | 17,77 | 17,95 | -0,33% | 1,98% | 3.378.962 |
| 10/05/1993 | 17,89 | 18,19 | 17,83 | 18,01 | +1,68% | 2,00% | 4.297.010 |
| 07/05/1993 | 17,95 | 18,01 | 17,71 | 17,71 | -1,00% | 1,66% | 2.598.202 |
| 06/05/1993 | 18,13 | 18,19 | 17,77 | 17,89 | -1,96% | 2,30% | 4.593.594 |
| 05/05/1993 | 18,25 | 18,55 | 18,19 | 18,25 | -0,33% | 1,96% | 6.014.053 |
| 04/05/1993 | 18,31 | 18,61 | 18,13 | 18,31 | +0,33% | 2,61% | 6.697.139 |
| 03/05/1993 | 17,77 | 18,25 | 17,71 | 18,25 | +3,38% | 3,02% | 7.402.234 |
| 30/04/1993 | 17,71 | 18,01 | 17,59 | 17,65 | +0,00% | 2,36% | 4.970.245 |
| 29/04/1993 | 17,83 | 17,83 | 17,47 | 17,65 | -1,00% | 2,01% | 2.891.013 |
| 28/04/1993 | 17,89 | 17,95 | 17,59 | 17,83 | +0,67% | 2,00% | 7.006.509 |
| 27/04/1993 | 17,24 | 17,89 | 17,24 | 17,71 | +2,77% | 3,81% | 9.263.901 |
| 26/04/1993 | 17,00 | 17,35 | 16,94 | 17,24 | +0,35% | 2,46% | 4.473.493 |